RxDoctor Payments Data

Joseph Ciampoli

Foot & Ankle Surgery · Wilmington, DENPI 1588602080

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Smith+Nephew at 39.7% of the total. That places this record below the midpoint for foot & ankle surgery clinicians in DE, where the typical reported total is $3,171.

$2,493in general payments, 2019–2025

Across 92 payments — averaging $27.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$990
  • AbbVie$359
  • Medtronic$303
  • Paratek Pharmaceuticals, Inc.$168
  • Kerecis Limited$147
  • Organogenesis Inc.$116
  • plus $411 from 13 others

What the payments were for

  • Food & beverage$2,493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,493 in reported general payments places this provider in the 45th percentile of 32 foot & ankle surgery providers in Delaware.

See all foot & ankle surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$145,477
Medicare patients
439
Services billed
3,153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl64$929
Cephalexin24$264
Meloxicam34$234
Doxycycline Hyclate25$232
Levofloxacin11$182
Ammonium Lactate12$176
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$143
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$98

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →